Pola Kuman dan Uji Sensitivitas Pasien Infeksi Luka Operasi Bedah Digestif RSUP H. Adam Malik Medan Periode Januari-Juni 2015
LAMPIRAN 1
DAFTAR RIWAYAT HIDUP
Nama
: Revin Hira Khairinnisa
Jenis Kelamin
: Perempuan
Tempat / Tanggal Lahir
: Bandung, 11 April 1994
Warga Negara
: Indonesia
Status
: Belum Menikah
Agama
: Islam
Alamat
: Jl. Perjuangan 17, Tanjung Rejo, Medan
Sunggal
Nomer Handphone
: 081220706870
Email
: revinhira@gmail.com
Riwayat Pendidikan
:
1. TK Bahrul Ulum
(1997-1999)
2. SDN Banjarsari II
(1999-2005)
3. SMPN 5 Bandung
(2005-2008)
4. SMAN 2 Bandung
(2008-2011)
Riwayat Organisasi dan Pelatihan :
1. Seminar dan Workshop Medan Emergency Meeting 2013
Universitas Sumatera Utara
LAMPIRAN 2
Universitas Sumatera Utara
LAMPIRAN 3
Universitas Sumatera Utara
LAMPIRAN 4
Universitas Sumatera Utara
LAMPIRAN 5
No. Rekam
Medis
21.65.03
63.74.05
64.14.06
63.39.08
63.77.08
64.57.09
64.61.15
63.47.19
63.55.25
Jenis
Kelamin
L
L
L
L
P
L
P
P
L
Operasi
Kultur
Tanggal
04-05-2015
26-03-2015
13-05-2015
18-02-2015
10-04-2015
22-06-2015
25-06-2015
25-02-2015
06-03-2015
Jenis
Apendiktomi
Laparotomi
Eksisi lokal lesi rektal
Laparotomi
Laparotomi
Laparotomi
Apendiktomi
Laparotomi + Apendiktomi
Laprotomi
63.39.31
63.66.34
L
P
18-02-2015
22-03-2015
Apendiktomi
Laparotomi
Tanggal
07-05-2015
31-03-2015
22-05-2015
24-02-2015
20-04-2015
23-06-2015
26-06-2015
03-03-2015
09-03-2015
18-03-2015
23-02-2015
25-03-2015
63.06.34
P
62.97.36
64.20.38
63.27.40
63.20.53
L
P
L
L
21-01-2015
30-01-2015
23-01-2015
12-05-2015
09-02-2015
27-02-2015
Laparotomi
Laparotomi
Gastrostomi
Laparotomi
Laparotomi
Gastrostomi
26-01-2015
02-02-2015
05-02-2015
13-05-2015
13-02-2015
09-03-2015
63.17.56
L
P
Laparotomi
Anastomosis
Hemikolektomi kanan
06-02-2015
63.66.66
29-01-2015
04-03-2015
24-03-2015
31-03-2015
Bakteri
E. coli
E. coli
E. coli
E. coli
K. pneumonia
E. coli
E. coli
E. coli
E. coli
E. coli
E. coli
E. coli
K. pneumonia
E. coli
E. coli
K. pneumonia
P. aeruginosa
E. coli
K. pneumonia
A. baumanii
P. aeruginosa
E. coli
K. pneumonia
E. coli
Universitas Sumatera Utara
63.58.68
63.49.71
64.50.72
63.06.80
26.85.80
62.93.81
P
L
L
L
L
L
17-03-2015
28-02-2015
14-06-2015
20-01-2015
14-05-2015
09-01-2015
Laparotomi
Laparotomi + Apendiktomi
Laparotomi
Laparotomi
Apendiktomi
Laparotomi
06-04-2015
02-03-2015
15-06-2015
11-02-2015
15-05-2015
11-01-2015
12-01-2015
L. gasseri
E. coli
E. coli
E. coli
E. coli
E. coli
E. coli
P. aeruginosa
Universitas Sumatera Utara
Tabel 1
No.
No. Rekam
Medis
Jenis
Kelamin
Pola Kuman
1
2
3
4
5
6
7
8
9
21.65.03
63.74.05
64.14.06
63.39.08
63.77.08
64.57.09
64.61.15
63.47.19
63.55.25
L
L
L
L
P
L
P
P
L
10
11
63.39.31
63.66.34
L
P
12
63.06.34
P
13
14
15
16
62.97.36
64.20.38
63.27.40
63.20.53
L
P
L
L
17
63.17.56
L
18
63.66.66
P
19
63.58.68
P
E. coli
E. coli
E. coli
E. coli
K. pneumonia
E. coli
E. coli
E. coli
E. coli
E. coli
E. coli
E. coli
K. pneumonia
E. coli
E. coli
K. pneumonia
P. aeruginosa
E. coli
P. aeruginosa
A. baumanii
P. aeruginosa
E. coli
K. pneumonia
E. coli
E. coli
Sensitivitas Terhadap Antibiotik (S)/(R)
Amikacin Ampicillin/
Amoxicillin/
Cefotaxime
Sulbactam Clavulanic Acid
S
R
S
S
S
R
R
R
S
R
R
R
S
S
S
S
S
R
R
R
S
R
S
S
S
R
S
S
S
R
R
R
S
R
S
R
S
R
S
R
S
R
R
R
S
R
R
R
S
R
R
R
S
R
S
R
S
R
R
R
S
R
R
R
S
R
R
R
S
R
R
R
S
R
R
R
S
R
R
R
S
R
R
R
S
R
R
R
S
R
S
R
S
R
S
R
S
R
S
R
Universitas Sumatera Utara
20
21
22
23
24
63.49.71
64.50.72
63.06.80
26.85.80
62.93.81
L
L
L
L
L
No.
1
2
3
4
5
6
7
8
9
No. Rekam
Medis
21.65.03
63.74.05
64.14.06
63.39.08
63.77.08
64.57.09
64.61.15
63.47.19
63.55.25
Jenis
Kelamin
L
L
L
L
P
L
P
P
L
10
11
63.39.31
63.66.34
L
P
12
63.06.34
P
13
14
15
62.97.36
64.20.38
63.27.40
L
P
L
E. coli
E. coli
E. coli
E. coli
E. coli
P. aeruginosa
S
S
S
S
S
S
R
R
R
R
R
R
R
S
S
R
R
R
R
S
R
S
R
R
Tabel 2
Pola Kuman
E. coli
E. coli
E. coli
E. coli
K. pneumonia
E. coli
E. coli
E. coli
E. coli
E. coli
E. coli
E. coli
K. pneumonia
E. coli
E. coli
K. pneumonia
P. aeruginosa
E. coli
Sensitivitas Terhadap Antibiotik (S)/(R)
Ceftizidime Ceftriaxone Imipenem Cefoperazone
S
S
S
S
R
R
R
R
R
R
S
R
S
S
S
S
R
R
S
R
S
S
S
S
S
S
S
S
R
R
S
S
R
R
S
S
R
R
S
S
R
R
S
S
R
R
S
S
R
R
S
S
R
R
S
S
R
R
S
S
R
R
S
S
S
R
S
S
R
R
S
R
Universitas Sumatera Utara
16
63.20.53
L
17
63.17.56
L
18
63.66.66
P
19
20
21
22
23
24
63.58.68
63.49.71
64.50.72
63.06.80
26.85.80
62.93.81
P
L
L
L
L
L
P. aeruginosa
A. baumanii
P. aeruginosa
E. coli
K. pneumonia
E. coli
E. coli
E. coli
E. coli
E. coli
E. coli
E. coli
P. aeruginosa
R
R
S
R
R
R
R
R
S
R
S
R
S
R
R
R
R
R
R
R
R
S
R
S
R
R
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
Tabel 3
No.
1
2
3
4
5
6
7
8
9
No. Rekam
Medis
21.65.03
63.74.05
64.14.06
63.39.08
63.77.08
64.57.09
64.61.15
63.47.19
63.55.25
Jenis
Kelamin
L
L
L
L
P
L
P
P
L
10
63.39.31
L
Pola Kuman
E. coli
E. coli
E. coli
E. coli
K. pneumonia
E. coli
E. coli
E. coli
E. coli
E. coli
E. coli
Sensitivitas Terhadap Antibiotik (S)/(R)
Doxycycline Chloramphenicole Ciprofloxacin Cortimoxazole
R
R
S
R
R
S
R
R
R
R
R
R
S
Universitas Sumatera Utara
11
63.66.34
P
12
63.06.34
P
13
14
15
16
62.97.36
64.20.38
63.27.40
63.20.53
L
P
L
L
17
63.17.56
L
18
63.66.66
P
19
20
21
22
23
24
63.58.68
63.49.71
64.50.72
63.06.80
26.85.80
62.93.81
P
L
L
L
L
L
E. coli
K. pneumonia
E. coli
E. coli
K. pneumonia
P. aeruginosa
E. coli
P. aeruginosa
A. baumanii
P. aeruginosa
E. coli
K. pneumonia
E. coli
E. coli
E. coli
E. coli
E. coli
E. coli
E. coli
P. aeruginosa
R
R
R
R
R
R
R
R
S
R
R
R
R
R
R
R
R
R
R
R
Tabel 4
No.
1
2
3
4
No. Rekam
Medis
21.65.03
63.74.05
64.14.06
63.39.08
Jenis
Kelamin
L
L
L
L
Pola Kuman
E. coli
E. coli
E. coli
E. coli
Sensitivitas Terhadap Antibiotik (S)/(R)
Gentamycin Levofloxacin Meropenem Netilmicin
S
S
S
S
R
R
S
S
S
Universitas Sumatera Utara
5
6
7
8
9
63.77.08
64.57.09
64.61.15
63.47.19
63.55.25
P
L
P
P
L
10
11
63.39.31
63.66.34
L
P
12
63.06.34
P
13
14
15
16
62.97.36
64.20.38
63.27.40
63.20.53
L
P
L
L
17
63.17.56
L
18
63.66.66
P
19
20
21
22
23
24
63.58.68
63.49.71
64.50.72
63.06.80
26.85.80
62.93.81
P
L
L
L
L
L
K. pneumonia
E. coli
E. coli
E. coli
E. coli
E. coli
E. coli
E. coli
K. pneumonia
E. coli
E. coli
K. pneumonia
P. aeruginosa
E. coli
P. aeruginosa
A. baumanii
P. aeruginosa
E. coli
K. pneumonia
E. coli
E. coli
E. coli
E. coli
E. coli
E. coli
E. coli
P. aeruginosa
R
S
R
S
R
R
S
S
R
S
R
S
S
R
S
R
S
R
R
R
R
S
S
S
S
S
S
R
S
R
R
S
S
R
R
R
R
R
S
S
R
S
R
S
R
R
R
R
R
S
R
S
R
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
R
Universitas Sumatera Utara
Tabel 5
No.
1
2
3
4
5
6
7
8
9
No. Rekam
Medis
21.65.03
63.74.05
64.14.06
63.39.08
63.77.08
64.57.09
64.61.15
63.47.19
63.55.25
Jenis
Kelamin
L
L
L
L
P
L
P
P
L
10
11
63.39.31
63.66.34
L
P
12
63.06.34
P
13
14
15
16
62.97.36
64.20.38
63.27.40
63.20.53
L
P
L
L
17
63.17.56
L
18
63.66.66
P
19
20
63.58.68
63.49.71
P
L
Pola Kuman
E. coli
E. coli
E. coli
E. coli
K. pneumonia
E. coli
E. coli
E. coli
E. coli
E. coli
E. coli
E. coli
K. pneumonia
E. coli
E. coli
K. pneumonia
P. aeruginosa
E. coli
P. aeruginosa
A. baumanii
P. aeruginosa
E. coli
K. pneumonia
E. coli
E. coli
E. coli
Sensitivitas Terhadap Antibiotik (S)/(R)
Piperacillin-Tazobactam Tetracycline Polymyxin B
S
S
R
S
S
S
S
S
R
S
S
S
S
S
R
R
S
R
R
R
R
S
S
S
S
S
R
R
R
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
Universitas Sumatera Utara
21
22
23
24
64.50.72
63.06.80
26.85.80
62.93.81
L
L
L
L
E. coli
E. coli
E. coli
E. coli
P. aeruginosa
S
S
R
S
S
S
S
S
Universitas Sumatera Utara
LAMPIRAN 6
Jenis Operasi * ILO Crosstabulation
% within Jenis Operasi
ILO
Positif
Jenis Operasi
Negatif
Total
Apendiktomi
14.3%
85.7%
100.0%
Laparotomi
17.4%
82.6%
100.0%
3.3%
96.7%
100.0%
Gastrostomi
18.2%
81.8%
100.0%
Hemikolektomi kanan
16.7%
83.3%
100.0%
5.9%
94.1%
100.0%
Laparotomi + Apendiktomi
Anastomosis
Eksisi lokal lesi rektal
100.0%
100.0%
Bedah digestif lainnya
Total
100.0%
100.0%
94.0%
100.0%
6.0%
Jenis Operasi
Cumulative
Frequency
Valid
Percent
Valid Percent
Percent
Apendiktomi
28
6.4
6.4
6.4
Laparotomi
86
19.7
19.7
26.1
Laparotomi + Apendiktomi
61
14.0
14.0
40.1
Gastrostomi
11
2.5
2.5
42.7
6
1.4
1.4
44.0
17
3.9
3.9
47.9
1
.2
.2
48.2
Bedah digestif lainnya
226
51.8
51.8
100.0
Total
436
100.0
100.0
Hemikolektomi kanan
Anastomosis
Eksisi lokal lesi rektal
Universitas Sumatera Utara
Pola Bakteri
Frequency
Percent
Valid Percent
Cumulative
Percent
E. coli
22
68.8
68.8
68.8
K. pneumonia
5
15.6
15.6
84.4
P. aeruginosa
3
9.4
9.4
93.8
A. baumanii
1
3.1
3.1
96.9
L. gasseri
1
3.1
3.1
100.0
32
100.0
100.0
Valid
Total
Universitas Sumatera Utara
Antibiotik * Sensitivitas Crosstabulation
% within Antibiotik
Sensitivitas
S
Antibiotik
Amikacin
Ampicillin/Sulbactam
R
100.0%
100.0%
3.2%
96.8%
100.0%
Amoxicillin/Clavulanic acid
38.7%
61.3%
100.0%
Cefotaxime
19.4%
80.6%
100.0%
Ceftizidime
29.0%
71.0%
100.0%
Ceftriaxone
19.4%
80.6%
100.0%
Imipenem
96.8%
3.2%
100.0%
Cefoperazone/Sulbactam
87.1%
12.9%
100.0%
Doxycycline
10.0%
90.0%
100.0%
Gentamycin
62.1%
37.9%
100.0%
Levofloxacin
43.3%
56.7%
100.0%
Meropenem
96.7%
3.3%
100.0%
100.0%
100.0%
33.3%
100.0%
100.0%
100.0%
Netilmicin
Piperacillin-Tazobactam
66.7%
Tetracycline
Total
Total
Polymyxin B
100.0%
100.0%
Chloramphenicole
100.0%
100.0%
Ciprofloxacin
100.0%
100.0%
Cortimoxazole
100.0%
100.0%
45.8%
100.0%
54.2%
Universitas Sumatera Utara
Sensitivitas * E. coli Crosstabulation
% within Sensitivitas
E. coli
S
Sensitivitas
Amikacin
Ampicillin/Sulbactam
R
100.0%
100.0%
4.5%
95.5%
100.0%
Amoxicillin/Clavulanic acid
50.0%
50.0%
100.0%
Cefotaxime
27.3%
72.7%
100.0%
Ceftizidime
27.3%
72.7%
100.0%
Ceftriaxone
27.3%
72.7%
100.0%
Imipenem
95.5%
4.5%
100.0%
Cefoperazone/Sulbactam
86.4%
13.6%
100.0%
Doxycycline
9.5%
90.5%
100.0%
Gentamycin
65.0%
35.0%
100.0%
Levofloxacin
33.3%
66.7%
100.0%
Meropenem
95.2%
4.8%
100.0%
100.0%
100.0%
33.3%
100.0%
100.0%
100.0%
Netilmicin
Piperacillin-Tazobactam
66.7%
Tetracycline
Total
Total
Polymyxin B
100.0%
100.0%
Chloramphenicole
100.0%
100.0%
Ciprofloxacin
100.0%
100.0%
Cortimoxazole
100.0%
100.0%
44.7%
100.0%
55.3%
Universitas Sumatera Utara
K. pneumonia * Sensitivitas Crosstabulation
% within K. Pneumonia
Sensitivitas
S
K. Pneumonia
Amikacin
Total
100.0%
Ampicillin/Sulbactam
100.0%
100.0%
100.0%
80.0%
100.0%
Cefotaxime
100.0%
100.0%
Ceftizidime
100.0%
100.0%
Ceftriaxone
100.0%
100.0%
Amoxicillin/Clavulanic Acid
Imipenem
Cefoperazone/Sulbactam
20.0%
100.0%
80.0%
Doxycycline
100.0%
20.0%
100.0%
100.0%
100.0%
Gentamycin
40.0%
60.0%
100.0%
Levofloxacin
40.0%
60.0%
100.0%
Meropenem
100.0%
Piperacillin-Tazobactam
Polymyxin B
Total
R
80.0%
100.0%
20.0%
100.0%
46.4%
100.0%
100.0%
53.6%
100.0%
Universitas Sumatera Utara
Sensitivitas * P.aeruginosa Crosstabulation
% within Sensitivitas
P.aeruginosa
S
Sensitivitas
Amikacin
100.0%
Total
100.0%
Ampicillin/Sulbactam
100.0%
100.0%
Amoxicillin/Clavulanic acid
100.0%
100.0%
Cefotaxime
100.0%
100.0%
Ceftizidime
100.0%
Ceftriaxone
100.0%
100.0%
100.0%
Imipenem
100.0%
100.0%
Cefoperazone/Sulbactam
100.0%
100.0%
Doxycycline
100.0%
100.0%
Gentamycin
100.0%
100.0%
Levofloxacin
100.0%
100.0%
Meropenem
100.0%
100.0%
Piperacillin-Tazobactam
66.7%
Tetracycline
Polymyxin B
Total
R
33.3%
100.0%
100.0%
100.0%
100.0%
60.5%
100.0%
39.5%
100.0%
Universitas Sumatera Utara
A. baumanii * Sensitivitas Crosstabulation
% within A. baumanii
Sensitivitas
S
A. baumanii
Amikacin
R
100.0%
Total
100.0%
Ampicillin/Sulbactam
100.0%
100.0%
Amoxicillin/Clavulanic Acid
100.0%
100.0%
Cefotaxime
100.0%
100.0%
Ceftizidime
100.0%
100.0%
Ceftriaxone
100.0%
100.0%
Imipenem
100.0%
100.0%
Cefoperazone/Sulbactam
100.0%
100.0%
Doxycyline
100.0%
100.0%
Gentamycin
100.0%
100.0%
Levofloxacin
100.0%
100.0%
Meropenem
100.0%
Piperacillin-Tazobactam
Polymyxin B
100.0%
100.0%
100.0%
Total
42.9%
100.0%
100.0%
57.1%
100.0%
Universitas Sumatera Utara
DAFTAR RIWAYAT HIDUP
Nama
: Revin Hira Khairinnisa
Jenis Kelamin
: Perempuan
Tempat / Tanggal Lahir
: Bandung, 11 April 1994
Warga Negara
: Indonesia
Status
: Belum Menikah
Agama
: Islam
Alamat
: Jl. Perjuangan 17, Tanjung Rejo, Medan
Sunggal
Nomer Handphone
: 081220706870
: revinhira@gmail.com
Riwayat Pendidikan
:
1. TK Bahrul Ulum
(1997-1999)
2. SDN Banjarsari II
(1999-2005)
3. SMPN 5 Bandung
(2005-2008)
4. SMAN 2 Bandung
(2008-2011)
Riwayat Organisasi dan Pelatihan :
1. Seminar dan Workshop Medan Emergency Meeting 2013
Universitas Sumatera Utara
LAMPIRAN 2
Universitas Sumatera Utara
LAMPIRAN 3
Universitas Sumatera Utara
LAMPIRAN 4
Universitas Sumatera Utara
LAMPIRAN 5
No. Rekam
Medis
21.65.03
63.74.05
64.14.06
63.39.08
63.77.08
64.57.09
64.61.15
63.47.19
63.55.25
Jenis
Kelamin
L
L
L
L
P
L
P
P
L
Operasi
Kultur
Tanggal
04-05-2015
26-03-2015
13-05-2015
18-02-2015
10-04-2015
22-06-2015
25-06-2015
25-02-2015
06-03-2015
Jenis
Apendiktomi
Laparotomi
Eksisi lokal lesi rektal
Laparotomi
Laparotomi
Laparotomi
Apendiktomi
Laparotomi + Apendiktomi
Laprotomi
63.39.31
63.66.34
L
P
18-02-2015
22-03-2015
Apendiktomi
Laparotomi
Tanggal
07-05-2015
31-03-2015
22-05-2015
24-02-2015
20-04-2015
23-06-2015
26-06-2015
03-03-2015
09-03-2015
18-03-2015
23-02-2015
25-03-2015
63.06.34
P
62.97.36
64.20.38
63.27.40
63.20.53
L
P
L
L
21-01-2015
30-01-2015
23-01-2015
12-05-2015
09-02-2015
27-02-2015
Laparotomi
Laparotomi
Gastrostomi
Laparotomi
Laparotomi
Gastrostomi
26-01-2015
02-02-2015
05-02-2015
13-05-2015
13-02-2015
09-03-2015
63.17.56
L
P
Laparotomi
Anastomosis
Hemikolektomi kanan
06-02-2015
63.66.66
29-01-2015
04-03-2015
24-03-2015
31-03-2015
Bakteri
E. coli
E. coli
E. coli
E. coli
K. pneumonia
E. coli
E. coli
E. coli
E. coli
E. coli
E. coli
E. coli
K. pneumonia
E. coli
E. coli
K. pneumonia
P. aeruginosa
E. coli
K. pneumonia
A. baumanii
P. aeruginosa
E. coli
K. pneumonia
E. coli
Universitas Sumatera Utara
63.58.68
63.49.71
64.50.72
63.06.80
26.85.80
62.93.81
P
L
L
L
L
L
17-03-2015
28-02-2015
14-06-2015
20-01-2015
14-05-2015
09-01-2015
Laparotomi
Laparotomi + Apendiktomi
Laparotomi
Laparotomi
Apendiktomi
Laparotomi
06-04-2015
02-03-2015
15-06-2015
11-02-2015
15-05-2015
11-01-2015
12-01-2015
L. gasseri
E. coli
E. coli
E. coli
E. coli
E. coli
E. coli
P. aeruginosa
Universitas Sumatera Utara
Tabel 1
No.
No. Rekam
Medis
Jenis
Kelamin
Pola Kuman
1
2
3
4
5
6
7
8
9
21.65.03
63.74.05
64.14.06
63.39.08
63.77.08
64.57.09
64.61.15
63.47.19
63.55.25
L
L
L
L
P
L
P
P
L
10
11
63.39.31
63.66.34
L
P
12
63.06.34
P
13
14
15
16
62.97.36
64.20.38
63.27.40
63.20.53
L
P
L
L
17
63.17.56
L
18
63.66.66
P
19
63.58.68
P
E. coli
E. coli
E. coli
E. coli
K. pneumonia
E. coli
E. coli
E. coli
E. coli
E. coli
E. coli
E. coli
K. pneumonia
E. coli
E. coli
K. pneumonia
P. aeruginosa
E. coli
P. aeruginosa
A. baumanii
P. aeruginosa
E. coli
K. pneumonia
E. coli
E. coli
Sensitivitas Terhadap Antibiotik (S)/(R)
Amikacin Ampicillin/
Amoxicillin/
Cefotaxime
Sulbactam Clavulanic Acid
S
R
S
S
S
R
R
R
S
R
R
R
S
S
S
S
S
R
R
R
S
R
S
S
S
R
S
S
S
R
R
R
S
R
S
R
S
R
S
R
S
R
R
R
S
R
R
R
S
R
R
R
S
R
S
R
S
R
R
R
S
R
R
R
S
R
R
R
S
R
R
R
S
R
R
R
S
R
R
R
S
R
R
R
S
R
R
R
S
R
S
R
S
R
S
R
S
R
S
R
Universitas Sumatera Utara
20
21
22
23
24
63.49.71
64.50.72
63.06.80
26.85.80
62.93.81
L
L
L
L
L
No.
1
2
3
4
5
6
7
8
9
No. Rekam
Medis
21.65.03
63.74.05
64.14.06
63.39.08
63.77.08
64.57.09
64.61.15
63.47.19
63.55.25
Jenis
Kelamin
L
L
L
L
P
L
P
P
L
10
11
63.39.31
63.66.34
L
P
12
63.06.34
P
13
14
15
62.97.36
64.20.38
63.27.40
L
P
L
E. coli
E. coli
E. coli
E. coli
E. coli
P. aeruginosa
S
S
S
S
S
S
R
R
R
R
R
R
R
S
S
R
R
R
R
S
R
S
R
R
Tabel 2
Pola Kuman
E. coli
E. coli
E. coli
E. coli
K. pneumonia
E. coli
E. coli
E. coli
E. coli
E. coli
E. coli
E. coli
K. pneumonia
E. coli
E. coli
K. pneumonia
P. aeruginosa
E. coli
Sensitivitas Terhadap Antibiotik (S)/(R)
Ceftizidime Ceftriaxone Imipenem Cefoperazone
S
S
S
S
R
R
R
R
R
R
S
R
S
S
S
S
R
R
S
R
S
S
S
S
S
S
S
S
R
R
S
S
R
R
S
S
R
R
S
S
R
R
S
S
R
R
S
S
R
R
S
S
R
R
S
S
R
R
S
S
R
R
S
S
S
R
S
S
R
R
S
R
Universitas Sumatera Utara
16
63.20.53
L
17
63.17.56
L
18
63.66.66
P
19
20
21
22
23
24
63.58.68
63.49.71
64.50.72
63.06.80
26.85.80
62.93.81
P
L
L
L
L
L
P. aeruginosa
A. baumanii
P. aeruginosa
E. coli
K. pneumonia
E. coli
E. coli
E. coli
E. coli
E. coli
E. coli
E. coli
P. aeruginosa
R
R
S
R
R
R
R
R
S
R
S
R
S
R
R
R
R
R
R
R
R
S
R
S
R
R
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
Tabel 3
No.
1
2
3
4
5
6
7
8
9
No. Rekam
Medis
21.65.03
63.74.05
64.14.06
63.39.08
63.77.08
64.57.09
64.61.15
63.47.19
63.55.25
Jenis
Kelamin
L
L
L
L
P
L
P
P
L
10
63.39.31
L
Pola Kuman
E. coli
E. coli
E. coli
E. coli
K. pneumonia
E. coli
E. coli
E. coli
E. coli
E. coli
E. coli
Sensitivitas Terhadap Antibiotik (S)/(R)
Doxycycline Chloramphenicole Ciprofloxacin Cortimoxazole
R
R
S
R
R
S
R
R
R
R
R
R
S
Universitas Sumatera Utara
11
63.66.34
P
12
63.06.34
P
13
14
15
16
62.97.36
64.20.38
63.27.40
63.20.53
L
P
L
L
17
63.17.56
L
18
63.66.66
P
19
20
21
22
23
24
63.58.68
63.49.71
64.50.72
63.06.80
26.85.80
62.93.81
P
L
L
L
L
L
E. coli
K. pneumonia
E. coli
E. coli
K. pneumonia
P. aeruginosa
E. coli
P. aeruginosa
A. baumanii
P. aeruginosa
E. coli
K. pneumonia
E. coli
E. coli
E. coli
E. coli
E. coli
E. coli
E. coli
P. aeruginosa
R
R
R
R
R
R
R
R
S
R
R
R
R
R
R
R
R
R
R
R
Tabel 4
No.
1
2
3
4
No. Rekam
Medis
21.65.03
63.74.05
64.14.06
63.39.08
Jenis
Kelamin
L
L
L
L
Pola Kuman
E. coli
E. coli
E. coli
E. coli
Sensitivitas Terhadap Antibiotik (S)/(R)
Gentamycin Levofloxacin Meropenem Netilmicin
S
S
S
S
R
R
S
S
S
Universitas Sumatera Utara
5
6
7
8
9
63.77.08
64.57.09
64.61.15
63.47.19
63.55.25
P
L
P
P
L
10
11
63.39.31
63.66.34
L
P
12
63.06.34
P
13
14
15
16
62.97.36
64.20.38
63.27.40
63.20.53
L
P
L
L
17
63.17.56
L
18
63.66.66
P
19
20
21
22
23
24
63.58.68
63.49.71
64.50.72
63.06.80
26.85.80
62.93.81
P
L
L
L
L
L
K. pneumonia
E. coli
E. coli
E. coli
E. coli
E. coli
E. coli
E. coli
K. pneumonia
E. coli
E. coli
K. pneumonia
P. aeruginosa
E. coli
P. aeruginosa
A. baumanii
P. aeruginosa
E. coli
K. pneumonia
E. coli
E. coli
E. coli
E. coli
E. coli
E. coli
E. coli
P. aeruginosa
R
S
R
S
R
R
S
S
R
S
R
S
S
R
S
R
S
R
R
R
R
S
S
S
S
S
S
R
S
R
R
S
S
R
R
R
R
R
S
S
R
S
R
S
R
R
R
R
R
S
R
S
R
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
R
Universitas Sumatera Utara
Tabel 5
No.
1
2
3
4
5
6
7
8
9
No. Rekam
Medis
21.65.03
63.74.05
64.14.06
63.39.08
63.77.08
64.57.09
64.61.15
63.47.19
63.55.25
Jenis
Kelamin
L
L
L
L
P
L
P
P
L
10
11
63.39.31
63.66.34
L
P
12
63.06.34
P
13
14
15
16
62.97.36
64.20.38
63.27.40
63.20.53
L
P
L
L
17
63.17.56
L
18
63.66.66
P
19
20
63.58.68
63.49.71
P
L
Pola Kuman
E. coli
E. coli
E. coli
E. coli
K. pneumonia
E. coli
E. coli
E. coli
E. coli
E. coli
E. coli
E. coli
K. pneumonia
E. coli
E. coli
K. pneumonia
P. aeruginosa
E. coli
P. aeruginosa
A. baumanii
P. aeruginosa
E. coli
K. pneumonia
E. coli
E. coli
E. coli
Sensitivitas Terhadap Antibiotik (S)/(R)
Piperacillin-Tazobactam Tetracycline Polymyxin B
S
S
R
S
S
S
S
S
R
S
S
S
S
S
R
R
S
R
R
R
R
S
S
S
S
S
R
R
R
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
Universitas Sumatera Utara
21
22
23
24
64.50.72
63.06.80
26.85.80
62.93.81
L
L
L
L
E. coli
E. coli
E. coli
E. coli
P. aeruginosa
S
S
R
S
S
S
S
S
Universitas Sumatera Utara
LAMPIRAN 6
Jenis Operasi * ILO Crosstabulation
% within Jenis Operasi
ILO
Positif
Jenis Operasi
Negatif
Total
Apendiktomi
14.3%
85.7%
100.0%
Laparotomi
17.4%
82.6%
100.0%
3.3%
96.7%
100.0%
Gastrostomi
18.2%
81.8%
100.0%
Hemikolektomi kanan
16.7%
83.3%
100.0%
5.9%
94.1%
100.0%
Laparotomi + Apendiktomi
Anastomosis
Eksisi lokal lesi rektal
100.0%
100.0%
Bedah digestif lainnya
Total
100.0%
100.0%
94.0%
100.0%
6.0%
Jenis Operasi
Cumulative
Frequency
Valid
Percent
Valid Percent
Percent
Apendiktomi
28
6.4
6.4
6.4
Laparotomi
86
19.7
19.7
26.1
Laparotomi + Apendiktomi
61
14.0
14.0
40.1
Gastrostomi
11
2.5
2.5
42.7
6
1.4
1.4
44.0
17
3.9
3.9
47.9
1
.2
.2
48.2
Bedah digestif lainnya
226
51.8
51.8
100.0
Total
436
100.0
100.0
Hemikolektomi kanan
Anastomosis
Eksisi lokal lesi rektal
Universitas Sumatera Utara
Pola Bakteri
Frequency
Percent
Valid Percent
Cumulative
Percent
E. coli
22
68.8
68.8
68.8
K. pneumonia
5
15.6
15.6
84.4
P. aeruginosa
3
9.4
9.4
93.8
A. baumanii
1
3.1
3.1
96.9
L. gasseri
1
3.1
3.1
100.0
32
100.0
100.0
Valid
Total
Universitas Sumatera Utara
Antibiotik * Sensitivitas Crosstabulation
% within Antibiotik
Sensitivitas
S
Antibiotik
Amikacin
Ampicillin/Sulbactam
R
100.0%
100.0%
3.2%
96.8%
100.0%
Amoxicillin/Clavulanic acid
38.7%
61.3%
100.0%
Cefotaxime
19.4%
80.6%
100.0%
Ceftizidime
29.0%
71.0%
100.0%
Ceftriaxone
19.4%
80.6%
100.0%
Imipenem
96.8%
3.2%
100.0%
Cefoperazone/Sulbactam
87.1%
12.9%
100.0%
Doxycycline
10.0%
90.0%
100.0%
Gentamycin
62.1%
37.9%
100.0%
Levofloxacin
43.3%
56.7%
100.0%
Meropenem
96.7%
3.3%
100.0%
100.0%
100.0%
33.3%
100.0%
100.0%
100.0%
Netilmicin
Piperacillin-Tazobactam
66.7%
Tetracycline
Total
Total
Polymyxin B
100.0%
100.0%
Chloramphenicole
100.0%
100.0%
Ciprofloxacin
100.0%
100.0%
Cortimoxazole
100.0%
100.0%
45.8%
100.0%
54.2%
Universitas Sumatera Utara
Sensitivitas * E. coli Crosstabulation
% within Sensitivitas
E. coli
S
Sensitivitas
Amikacin
Ampicillin/Sulbactam
R
100.0%
100.0%
4.5%
95.5%
100.0%
Amoxicillin/Clavulanic acid
50.0%
50.0%
100.0%
Cefotaxime
27.3%
72.7%
100.0%
Ceftizidime
27.3%
72.7%
100.0%
Ceftriaxone
27.3%
72.7%
100.0%
Imipenem
95.5%
4.5%
100.0%
Cefoperazone/Sulbactam
86.4%
13.6%
100.0%
Doxycycline
9.5%
90.5%
100.0%
Gentamycin
65.0%
35.0%
100.0%
Levofloxacin
33.3%
66.7%
100.0%
Meropenem
95.2%
4.8%
100.0%
100.0%
100.0%
33.3%
100.0%
100.0%
100.0%
Netilmicin
Piperacillin-Tazobactam
66.7%
Tetracycline
Total
Total
Polymyxin B
100.0%
100.0%
Chloramphenicole
100.0%
100.0%
Ciprofloxacin
100.0%
100.0%
Cortimoxazole
100.0%
100.0%
44.7%
100.0%
55.3%
Universitas Sumatera Utara
K. pneumonia * Sensitivitas Crosstabulation
% within K. Pneumonia
Sensitivitas
S
K. Pneumonia
Amikacin
Total
100.0%
Ampicillin/Sulbactam
100.0%
100.0%
100.0%
80.0%
100.0%
Cefotaxime
100.0%
100.0%
Ceftizidime
100.0%
100.0%
Ceftriaxone
100.0%
100.0%
Amoxicillin/Clavulanic Acid
Imipenem
Cefoperazone/Sulbactam
20.0%
100.0%
80.0%
Doxycycline
100.0%
20.0%
100.0%
100.0%
100.0%
Gentamycin
40.0%
60.0%
100.0%
Levofloxacin
40.0%
60.0%
100.0%
Meropenem
100.0%
Piperacillin-Tazobactam
Polymyxin B
Total
R
80.0%
100.0%
20.0%
100.0%
46.4%
100.0%
100.0%
53.6%
100.0%
Universitas Sumatera Utara
Sensitivitas * P.aeruginosa Crosstabulation
% within Sensitivitas
P.aeruginosa
S
Sensitivitas
Amikacin
100.0%
Total
100.0%
Ampicillin/Sulbactam
100.0%
100.0%
Amoxicillin/Clavulanic acid
100.0%
100.0%
Cefotaxime
100.0%
100.0%
Ceftizidime
100.0%
Ceftriaxone
100.0%
100.0%
100.0%
Imipenem
100.0%
100.0%
Cefoperazone/Sulbactam
100.0%
100.0%
Doxycycline
100.0%
100.0%
Gentamycin
100.0%
100.0%
Levofloxacin
100.0%
100.0%
Meropenem
100.0%
100.0%
Piperacillin-Tazobactam
66.7%
Tetracycline
Polymyxin B
Total
R
33.3%
100.0%
100.0%
100.0%
100.0%
60.5%
100.0%
39.5%
100.0%
Universitas Sumatera Utara
A. baumanii * Sensitivitas Crosstabulation
% within A. baumanii
Sensitivitas
S
A. baumanii
Amikacin
R
100.0%
Total
100.0%
Ampicillin/Sulbactam
100.0%
100.0%
Amoxicillin/Clavulanic Acid
100.0%
100.0%
Cefotaxime
100.0%
100.0%
Ceftizidime
100.0%
100.0%
Ceftriaxone
100.0%
100.0%
Imipenem
100.0%
100.0%
Cefoperazone/Sulbactam
100.0%
100.0%
Doxycyline
100.0%
100.0%
Gentamycin
100.0%
100.0%
Levofloxacin
100.0%
100.0%
Meropenem
100.0%
Piperacillin-Tazobactam
Polymyxin B
100.0%
100.0%
100.0%
Total
42.9%
100.0%
100.0%
57.1%
100.0%
Universitas Sumatera Utara